Comments on: 23andme + Genetic Testing = Consumer Engagement http://www.medicinethink.com/23andme-genetic-testing-consumer-engagement/ devise and revise. Sun, 04 Dec 2011 16:39:54 +0000 hourly 1 http://wordpress.org/?v=3.2.1 By: Bradley Miller http://www.medicinethink.com/23andme-genetic-testing-consumer-engagement/comment-page-1/#comment-10547 Bradley Miller Thu, 13 May 2010 04:59:07 +0000 http://www.medicinethink.com/?p=588#comment-10547 The Insight Genomics announcement was a nice coincidence, indeed! The one thing I'd say toTom's comment is that correlating gene data to outcome data will be important - but that will require even more work and stickyness on 23andme's part. However, collecting phenotypic data along with the genomic data - that will allow for pretty powerful science as well in the future. The Insight Genomics announcement was a nice coincidence, indeed! The one thing I’d say toTom’s comment is that correlating gene data to outcome data will be important – but that will require even more work and stickyness on 23andme’s part. However, collecting phenotypic data along with the genomic data – that will allow for pretty powerful science as well in the future.

]]> By: TomPeddicord http://www.medicinethink.com/23andme-genetic-testing-consumer-engagement/comment-page-1/#comment-10546 TomPeddicord Wed, 12 May 2010 17:51:24 +0000 http://www.medicinethink.com/?p=588#comment-10546 With yesterday's announcement that Walgreens is offering the The Insight kit from Pathway Genomics for around $250, your blog couldn't have been more timely... Your thoughts above are similar to those discussed in the Decision Tree (http://thedecisiontree.com/blog/) in patients are able to collect so many more data points and our ability to correlate these with outcomes will potentially change how we monitor drug safety and other disease outcomes over time with these increased data points. Thanks, enjoyed your blog...if you follow me on twitter, we can continue the sharing of information....Cheers! With yesterday’s announcement that Walgreens is offering the The Insight kit from Pathway Genomics for around $250, your blog couldn’t have been more timely… Your thoughts above are similar to those discussed in the Decision Tree (http://thedecisiontree.com/blog/) in patients are able to collect so many more data points and our ability to correlate these with outcomes will potentially change how we monitor drug safety and other disease outcomes over time with these increased data points.

Thanks, enjoyed your blog…if you follow me on twitter, we can continue the sharing of information….Cheers!

]]>